Bristol-Myers Squibb Company (BMY)

BMY (NYSE:Drugs) EQUITY
$73.02
pos +1.40
+1.90%
Today's Range: 71.96 - 73.04 | BMY Avg Daily Volume: 5,929,800
Last Update: 06/29/16 - 2:18 PM EDT
Volume: 3,224,335
YTD Performance: 4.68%
Open: $72.10
Previous Close: $71.63
52 Week Range: $51.82 - $75.12
Oustanding Shares: 1,669,307,273
Market Cap: 117,385,687,437
6-Month Chart
TheStreet Ratings Grade for BMY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 7 6 6
Moderate Buy 1 1 1 1
Hold 7 7 6 6
Moderate Sell 0 0 0 0
Strong Sell 2 2 2 1
Mean Rec. 2.32 2.32 2.37 2.18
Latest Dividend: 0.38
Latest Dividend Yield: 2.16%
Dividend Ex-Date: 06/29/16
Price Earnings Ratio: 34.99
Price Earnings Comparisons:
BMY Sector Avg. S&P 500
34.99 75.20 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
14.72% 6.62% 61.13%
GROWTH 12 Mo 3 Yr CAGR
Revenue 4.30 -0.10 -0.02
Net Income -19.60 -0.30 -0.13
EPS -22.30 -0.20 -0.07
Earnings for BMY:
EBITDA 2.27B
Revenue 16.56B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $0.66 $0.64 $2.60 $3.33
Number of Analysts 7 5 11 10
High Estimate $0.68 $0.69 $2.71 $3.68
Low Estimate $0.64 $0.61 $2.53 $3.01
Prior Year $0.53 $0.39 $2.01 $2.60
Growth Rate (Year over Year) 24.26% 64.10% 29.49% 28.02%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Jun 28, 2016 | 9:45 AM EDT

One side lied, one side barely tried, the people voted for economic suicide, but it will not stick.  

By

Jim Cramer

 | Jun 22, 2016 | 10:47 AM EDT

This debate is not about EU control of Britain.

By

Bret Jensen

 | Jun 20, 2016 | 12:00 PM EDT

Large biotech stocks are still at their cheapest valuations since 2011.

By

Jim Cramer

 | Jun 15, 2016 | 6:24 AM EDT

This is the group that is the most dangerous politically.

By

Jim Cramer

 | Jun 10, 2016 | 10:36 AM EDT

And the usual suspects need to bottom or keep gaining.

By

Gary Morrow

 | Jun 6, 2016 | 3:17 PM EDT

The stock is gaining today with the help of a nice jump in volume.

By

Jim Cramer

 | Jun 3, 2016 | 11:17 AM EDT

Federal Reserve Chair Janet Yellen should say the Fed can't raise interest rates right now when she speaks in Philadelphia on Monday, according to Jim Cramer.

By

Jim Cramer

 | Jun 3, 2016 | 5:37 AM EDT

This is because they would buy more of the winning stocks lower.

bullishBristol-Myers numbers raised at Jefferies

May 5, 2016 | 6:52 AM EDT

Shares of BMY now seen reaching $75, according to Jefferies. Estimates also increased, givne a faster expected ramp for the Opdivo monotherapy. Hold rating. 

updateBMY Investor Mtg.

May 3, 2016 | 7:04 AM EDT

BMY - Bristol-Myers Squibb Co Annual Shareholders Meeting - 10AM

There is just not much to get excited about when looking at individual stock charts. I sc...
General Mills (GIS) surprised investors with a much better than expected 4th quarter today...
We still have to take this market one decision to the next.  The last decision was the ke...
The huge bounce back rally continues. Sequential Brands Group (SQBG), one of my buys on t...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.